Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific methyltransferase 2A | Starlite/ChEMBL | No references |
Trypanosoma brucei | hypothetical protein, conserved | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | cpg binding protein | 0.0037 | 0.1284 | 0.4131 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0144 | 0.1435 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0074 | 0.2744 | 0.959 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.1206 | 0.3642 |
Mycobacterium ulcerans | citrate (pro-3S)-lyase subunit beta | 0.003 | 0.1004 | 0.5 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0144 | 0.1435 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0144 | 0.1435 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.1284 | 0.443 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.2861 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0144 | 0.1435 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.1206 | 0.4154 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.2861 | 1 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0258 | 0.0311 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2861 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.1284 | 0.443 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2861 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0257 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.2861 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0257 | 1 | 1 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.1206 | 0.3655 |
Onchocerca volvulus | 0.0035 | 0.1206 | 0.5 | |
Mycobacterium ulcerans | hypothetical protein | 0.003 | 0.1004 | 0.5 |
Trichomonas vaginalis | Citrate lyase beta chain, putative | 0.003 | 0.1004 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0144 | 0.1435 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2861 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.0174 | 0.0509 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0144 | 0.1435 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.2861 | 1 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0144 | 0.1435 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0144 | 0.1435 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.2861 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0144 | 0.1435 |
Mycobacterium tuberculosis | Probable citrate (pro-3S)-lyase (beta subunit) CitE (citrase) (citratase) (citritase) (citridesmolase) (citrase aldolase) | 0.003 | 0.1004 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0144 | 0.1435 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0144 | 0.1435 |
Mycobacterium ulcerans | citrate lyase beta subunit, CitE_2 | 0.003 | 0.1004 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2861 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.2861 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.003 | 0.1004 | 0.5 |
Trichomonas vaginalis | helicase, putative | 0.0008 | 0.0144 | 0.1435 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0144 | 0.1435 |
Echinococcus granulosus | citrate lyase subunit beta protein | 0.003 | 0.1004 | 0.3089 |
Mycobacterium tuberculosis | Conserved protein | 0.003 | 0.1004 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0144 | 0.1435 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2861 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0257 | 1 | 0.5 |
Echinococcus granulosus | cpg binding protein | 0.0037 | 0.1284 | 0.4131 |
Echinococcus multilocularis | citrate lyase subunit beta protein | 0.003 | 0.1004 | 0.3089 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0144 | 0.1435 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0258 | 0.0311 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0066 | 0.2433 | 0.5 |
Brugia malayi | RNA binding protein | 0.0076 | 0.2861 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0144 | 0.1435 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.2861 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0144 | 0.1435 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0144 | 0.1435 |
Mycobacterium ulcerans | citrate (pro-3S)-lyase subunit beta | 0.003 | 0.1004 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 4.4668 uM | PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.